Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-25 @ 8:27 PM
Study NCT ID:
NCT05274269
Status:
COMPLETED
Last Update Posted:
2024-08-01
First Post:
2022-03-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-01
First Submit QC Date:
None
Study First Post Date:
2022-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-03
Results First Submit QC Date:
None
Results First Post Date:
2024-08-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-08-01
Last Update Post Date Type:
ACTUAL